Concepedia

Add-on Therapy

Add-On Therapy is a pharmacotherapeutic intervention introduced in addition to standard controller therapy in asthma management, distinguished by its role in further improving disease control when baseline treatment is insufficient.

1.5K

Publications

76.9K

Citations

9.3K

Authors

2.8K

Institutions

Publications per year

2017–2026

555

Variants

Add-on Pharmacotherapy

Parents

Publications

1.5K

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair et al. · The Lancet · 2016 · 1.4K citations

, , +17

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Marc Humbert, Richard Beasley, Jon G. Ayres et al. · Allergy · 2004 · 1.1K citations · Full text

, , +14

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

Kjeld Hermansen, Melanie J. Davies, Tadeusz Dereziński et al. · Diabetes Care · 2006 · 631 citations · Full text

, , +17

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Geoffrey Chupp, Eric Bradford, Frank C. Albers et al. · The Lancet Respiratory Medicine · 2017 · 590 citations

, , +14

Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension

Marius M. Hoeper, Robyn J. Barst, Robert C. Bourge et al. · Circulation · 2013 · 562 citations

, , +13

1–5 of 1.5K

Authors

9.3K

  1. DP
    David Price

    University of Aberdeen, United Kingdom

    12 publications · 617 citations

    11

    h-index

  2. PM
    Petra Moroni-Zentgraf

    Boehringer Ingelheim (Germany), Germany

    10 publications · 920 citations

    10

    h-index

  3. EH
    Eckard Hamelmann

    Charité - Universitätsmedizin Berlin, Germany

    7 publications · 397 citations

    7

    h-index

  4. SP
    Shamik Parikh

    AstraZeneca (United States), United States

    7 publications · 1.2K citations

    7

    h-index

  5. GW
    Giorgio Walter Canonica

    University of Genoa, Italy

    7 publications · 1.5K citations

    7

    h-index

1–5 of 9.3K

Institutions

2.8K

  1. Inserm

    Paris, France

    21 h-index

    93 publications

    5.9K citations

  2. Istituti di Ricovero e Cura a Carattere Scientifico

    Rome, Italy

    20 h-index

    75 publications

    3.7K citations

  3. Ludwig-Maximilians-Universität München

    Munich, Germany

    19 h-index

    91 publications

    5.5K citations

  4. Boehringer Ingelheim (Germany)

    Ingelheim, Germany

    18 h-index

    51 publications

    4.9K citations

  5. University College London

    London, United Kingdom

    17 h-index

    36 publications

    3.3K citations

  6. Heidelberg University

    Heidelberg, Germany

    17 h-index

    68 publications

    15.5K citations

  7. University of Pisa

    Pisa, Italy

    16 h-index

    29 publications

    2K citations

  8. Sapienza University of Rome

    Rome, Italy

    16 h-index

    102 publications

    2.4K citations

1–8 of 2.8K

Venues

  1. PubMed

    Repository · 65 publications · 1.6K citations

    23

    h-index

  2. Neurology

    29 publications · 3K citations

    23

    h-index

  3. Diabetes Obesity and Metabolism

    25 publications · 2.1K citations

    22

    h-index

  4. Diabetes Care

    20 publications · 4.1K citations

    19

    h-index

  5. Epilepsia

    21 publications · 1.4K citations

    19

    h-index

1–5